WYNTRA HOLDINGS LIMITED

Wyntra Holdings Limited is a pharmaceutical company focused on commercialising complex and differentiated prescription medicines for the United States and the United Kingdom. Drawing on the deep in-market and international experience of its leadership team, Wyntra delivers a portfolio that spans niche, complex generics for both retail and hospital settings, specialty brands that incorporate device technologies such as pre-filled syringes and bags, and repurposed or line-extension products that move from prescription-only to over-the-counter status. The firm also pursues turnaround opportunities, revitalising distressed assets with a clear commercial focus.

Guided by a set of core values - innovation, care and ethical conduct - Wyntra integrates sustainability into its operations, from renewable-energy partners and sustainable packaging to a digital supply-chain control tower. Its commitment to workplace equality, community engagement and robust governance underpins a culture that supports patients, employees and stakeholders alike. With a leadership team that brings over three decades of expertise across specialty and generic pharmaceuticals, Wyntra is positioned to bring novel solutions and new ways of working to the markets it serves.